Cargando…
Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target Clostridioides difficile
The US Centers for Disease Control and Prevention (CDC) lists Clostridioides difficile as an urgent bacterial threat. Yet, only two drugs, vancomycin and fidaxomicin, are approved by the FDA for the treatment of C. difficile infections as of this writing, while the global pipeline of new drugs is sp...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142968/ https://www.ncbi.nlm.nih.gov/pubmed/35631450 http://dx.doi.org/10.3390/ph15050623 |